Feed aggregator

This page is the text of all the cases associated with Lessons 1 and 2 of the IHI Open School course titled “Patient Safety 105: Communicating with Patients After Adverse Events.”

This three-day intensive program is designed to help primary care practices, networks, and systems sift through the myriad regulations, measurements, models, and demands to hone an essential set of skills and craft an organization-specific sequenced plan for primary care redesign that meets the needs of participating organizations and their communities.

This transcript is the text of all videos associated with Lesson 4 of the IHI Open School course titled “Patient Safety 105: Communicating with Patients After Adverse Events.”

ChrisHartman: TimeOut Capsules: Undeclared Drug Ingredient http://bit.ly/aD9JZp

During a 10-day trip to the north of Ghana, the IHI Project Fives Alive! team gathered stories and shared notes on the work of the sites they visited in Upper West, Upper East, and Northern Regions.

Product marketed as dietary supplement contains undeclared hydroxythiohomosildenafil, a chemical similar to sildenafil, which may interact with nitrates found in some prescription drugs and lower blood pressure to dangerous levels.

This transcript is the text of all videos associated with Lesson 3 of the IHI Open School course titled “Patient Safety 105: Communicating with Patients After Adverse Events."

This transcript is the text of all videos associated with Lesson 2 of the IHI Open School course titled “Patient Safety 105: Communicating with Patients After Adverse Events.”

ChrisHartman: MasXtreme Capsules (Natural Wellness) - product contains undeclared drug ingredient http://bit.ly/9IhLom

UPDATED 08/25/2010. Product marketed as dietary supplement contains undeclared Aminotadalafil, which may interact with nitrates found in some prescription drugs and lower blood pressure to dangerous levels.

ChrisHartman: Octagam [Immune Globulin Intravenous (human)] 5% Liquid Preparation: Recall - Risk of Thromboembolic Events http://bit.ly/cyA1x3

Customers asked to immediately quarantine the use of affected lots due to the potential for serious thromboembolic events.

ChrisHartman: Mr. Magic Male Enhancer: Undeclared Drug Ingredient http://bit.ly/9ii2RU

Product marketed as dietary supplement contains undeclared hydroxythiohomosildenafil and sulfoaildenafil, which may interact with nitrates found in some prescription drugs and lower blood pressure to dangerous levels.

ChrisHartman: INOMAX DS Drug-Delivery System: Class I Recall - Risk of Interruption of Drug Flow http://bit.ly/dAqe7c

Potential for failure of a pressure switch, which may have an impact on the administration of INOMAX for inhalation to patients.

ChrisHartman: Stalevo(carbidopa/levodopa and entacapone): Ongoing Safety Review: Possible increased cardiovascular risk http://bit.ly/diZHFX

FDA evaluating clinical trial data that suggest patients taking drug may be at an increased risk for cardiovascular events compared to those taking carbidopa/levodopa

This book examines the leadership characteristics of ten transformational leaders from a variety of work environments, including common themes, personal values, and the work environments these leaders have fostered. IHI President and CEO Maureen Bisognano is among the leaders profiled.

This article describes changes in rates of invasive health care-associated MRSA infections from 2005 through 2008 among residents of nine US metropolitan areas. Over the four-year period, the authors found that the rates decreased in two primary groups of patients: those with infections that began in the community and those with hospital-onset invasive disease.